Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors

Clinical trial NCT06256055 · UNKNOWN

Trial details

NCT number: NCT06256055
Sponsor: UTC Therapeutics Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Mesothelioma Colorectal Cancer Bile Duct Cancer Rectal Cancer Ovary Cancer Pancreatic Cancer Breast Cancer Female

Start date: 2024-03-05
Primary completion: 2025-03-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.